To evaluate the atherogenic role of VFEpoR RBCs in a model that mimics human polycythemia, we injected the same low-dose EPO into hyperlipidemic littermate EpoR-Cre control and VFEpoR mice that were fed the WD for 12 weeks. The gene discussed is EPO; the disease is polycythemia.